Trial Profile
The Immuno-Response to Primary Cryotherapy for the Treatment of Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sargramostim (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 22 Apr 2021 Status changed from active, no longer recruiting to completed.
- 05 Mar 2020 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 22 Mar 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.